Status:

ACTIVE_NOT_RECRUITING

Feasibility and Acceptability of Non Weight-bearing Physical Activity for People With Diabetic Foot Ulceration

Lead Sponsor:

Université du Québec à Trois-Rivières

Collaborating Sponsors:

Fondation Santé Trois-Rivières

Centre intégré universitaire de santé et services sociaux Mauricie et Centre-du-Québec (CIUSSS MCQ)

Conditions:

Diabetic Foot

Cardiopulmonary

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Intervention in the form of a PA (physical activity) program combining aerobic, resistance, and flexibility exercises adapted for wearing a lower limb offloading device and limiting weight-bearing on ...

Detailed Description

Objectives: 1. Evaluate the acceptability of a non-weight bearing physical activity (PA) program; 2. Assess the feasibility of the PA program and the data collection procedure; 3. Evaluate the feasib...

Eligibility Criteria

Inclusion

  • For individuals with a diabetic foot ulcer:
  • Inclusion:
  • Male or female
  • Aged over 18 up to 75 years
  • Willing to engage in PA (physical activity)
  • Committed to following wound care recommendations to the best of their ability for the duration of the study
  • Understand and read French.
  • Exclusion:
  • Uncontrolled DFU infection
  • Use of a non-removable offloading modality (total contact cast)
  • Uncontrolled hyperglycemia (HbA1c ≥ 10.0% or fasting blood glucose ≥ 16.0 mmol/L for ≥ 2 consecutive days) confirmed by blood sample results during the initial assessment or access to recent blood test results (within the last 3 months) or the log of home capillary blood glucose readings
  • Participation in sports or regular intense physical activities (≥ 2 times per week)
  • The following pre-existing heart problems: a cardiovascular event (myocardial infarction, heart surgery, etc.) in the last 3 months, unstable cardiovascular disease (uncontrolled hypertension, i.e., ≥ 160/90 mmHg, uncompensated heart failure, etc.), chest pain and exertional dyspnea and/or uninvestigated intermittent claudication
  • Recent neurovascular problem (stroke, transient ischemic attack, etc.) in the last 3 months
  • Health problem that the research team considers a contraindication to participating in the study
  • Diabetes complication making moderate-intensity PA unsafe, such as untreated proliferative diabetic retinopathy or a sensitivity disorder to hypoglycemia, critical ischemia of one or both lower limbs.
  • For kinesiologists:
  • Inclusion:
  • Have completed a bachelor's degree in kinesiology
  • Understand, read, and speak French.
  • Exclusion:
  • None

Exclusion

    Key Trial Info

    Start Date :

    December 1 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 1 2025

    Estimated Enrollment :

    12 Patients enrolled

    Trial Details

    Trial ID

    NCT06092827

    Start Date

    December 1 2023

    End Date

    September 1 2025

    Last Update

    May 13 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Universite du Quebec à Trois-Rivieres

    Trois-Rivières, Quebec, Canada, G8Z 4M3